Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®).

Document Type

Journal Article

Publication Date

3-15-2015

Journal

Diabetes & Vascular Disease Research

Peer Reviewed

1

Link to Full Text

Share

COinS